Johnson & Johnson vs Eli Lilly & Co.
JNJ vs LLY — side-by-side comparison from reported financials. JNJ leads 5, LLY leads 6 of 11 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | JNJ | LLY |
|---|---|---|
| Price | $261.79 | $1 177.20 |
| Market cap | $631B | $1.05T |
| Revenue (TTM) | $97.9B | $79.7B |
| Revenue growth | +5.6% | +31.7% |
| Net margin | 21.5% | 33.5% |
| Free cash flow | $22.2B | $18.2B |
| Net cash (debt) | ($27.8B) | ($35.2B) |
| 1-year price return | +37.0% | +37.6% |
| P/E | 29.9 | 41.6 |
| P/E vs own history (cheap-side %) | 16% | 88% |
| Dividend yield | 2.00% | 0.52% |
| Return on equity | 26% | 93% |
| Altman Z-score | — | 7.10 |
| CV checks passed | 10 of 11 | 11 of 11 |
| Employees | 140,800 | 50,000 |
Full résumé-style profiles: JNJ CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.